{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "53"
          },
          "Description in input context": "A53T mutation associated with early-onset Parkinson's disease"
        },
        {
          "HGVS": "NM_000340.3:c.90G>C",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "C",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation linked to familial Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005030"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunoprecipitation and Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing SNCA variants",
        "Description": "HEK293 cells were transfected with plasmids encoding wild-type or mutant SNCA proteins."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T variant exhibited increased α-synuclein aggregation compared to wild-type."
        },
        {
          "Variant": "NM_000340.3:c.90G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A30P variant showed enhanced oligomerization and reduced clearance rates."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across three independent cell cultures."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each Western blot was performed in triplicate with independent protein lysates."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA-expressing cells served as positive controls for normal protein function."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as negative controls for baseline aggregation."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with post-hoc Tukey's test for multiple comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Aggregation levels below 15% of wild-type controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Aggregation levels exceeding 40% of wild-type controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Standard methods for α-synuclein aggregation analysis in Parkinson's research."
      }
    }
  ]
}